Style de citation APA (7e éd.)

I, A., A, L., A, T., & E, B. (2019). Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin. Dove Medical Press.

Style de citation Chicago (17e éd.)

I, Avgerinos, Liakos A, Tsapas A, et Bekiari E. Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin. Dove Medical Press, 2019.

Style de citation MLA (8e éd.)

I, Avgerinos, et al. Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin. Dove Medical Press, 2019.